Pentose Phosphate Pathway Inhibition Metabolically Reprograms CD8⁺ T Cells and Disrupts CNS Autoimmunity

Inhibiting the pentose phosphate pathway disrupts CD8⁺ T cell metabolic reprogramming and effector functions, suggesting that such inhibition may serve as a therapeutic strategy to prevent neurodegeneration in patients with progressive multiple sclerosis.